Rational approach

The standard techniques used for 3D structural determinations are X-ray crystallography and NMR spectroscopy. Modeling of drug-receptor inter- 

To determine the structures of drug compounds or protein molecules using X-ray crystallography, it is necessary to have these compounds or molecules available in crystalline form. For example, when crystals of protein are formed, the protein molecules are arranged in orderly fashions like tiny imaginary cubes stacked on top of each other. Each of these building blocks contains a molecule of protein and is termed a unit cell (Fig. 3.3). 

For examining atomic structures with bond lengths of 1-2 A, the interrogating beams ideally should have wavelengths of the same dimensions, to resolve atomic details. X-rays fulfill this criterion because their wavelength, for example, CuK (X-ray using copper target) is 1.5418 A (1.5418 x 10 m), which is similar to atomic dimensions. 

When X-ray beams are focused on different orientations of these unit cells, the regular lattice arrangement scatters the X-ray and a 3D diffraction pattern consisting of thousands of diffraction spots is created. The intensity of each diffraction spot is the summation of constructive interference by the atoms 

It should be noted that F is a vector quantity with magnitude and direction (phase angle). 

When X-ray beams are focused on different orientations of these unit cells, the regular lattice arrangement scatters the X-ray and a 3D diffraction 

Structural determinations ol target protein/receptor using X-ray crystallography and/or NMR 

Modeling of drug molecules binding to active sites of protein/receptor using 

Synthesize drug molecules using combinatorial chemistry and test with HTS assay system 

Chapter 3 Drug Discovery Small Molecule Drugs 

---

T. Clark, Quantum chemoinformatics an oxymoron (Part 2), in Rational Approaches to Drug Design, H.-D. Holtje, W. Sippl (Eds.), Prous Science, Barcelona, 2001, pp. 29-40. 

Patani G A and E J LaVoie 1996. Bioisosterism A Rational Approach in Drug Design. Chemical Reviei 96 3147-3176. 

C. Sihpo and A. Vittoria, LMR Rational Approaches to the Design of Bioactive Compounds, Elsevier, Amsterdam, the Netherlands, 1991. 

Hazzon, M. J. and E. A. Warman, 1986, A Rational Approach to Emergency Planning AMS 1 ranee, November. 

This rational approach for the synthesis of isocorroles is complemented by observations discovered in investigations on porphycencs. Firstly as minor side products of the McMurry coupling of 2,2 -bipyrroles-5,5 -dicarbaldehydes, e.g. 3, isocorroles arc formed, e.g. 5.2... 

These experiments demonstrate that sapphyrins might be compounds of good stability, but that a rational approach is required to form sapphyrins in reasonable yields. 

In order to develop a rational approach to improving rates of metabolite production, it is necessary to consider the fate of the nutrients that are required for its synthesis. However, overcoming the major flux control points within a metabolic pathway may not lead to metabolite overproduction if the energetic consequences of the alteration are unfavourable to the organism. 

The foundation for the more rational approach to drug discovery that is practised today comes from basic research into disease processes and medical conditions. Much of this research is carried out in universities and other research institutions, with funding coming from both government and pharmaceutical industry sponsors. 

A number of approaches have been followed in attempts to create even more potent and durable inhibitory peptides including various rational approaches to increase peptide binding affinities, stability, and half-life (Dwyer et al. 2007), and the use of peptides such as 5-helix bearing multiple HR domains (Dimitrov et al. 2005). 

Moriarty E, Walker CH. 1987. Bioaccumulation in food chains-a rational approach. Ecotoxicol Environ Safety 13 208-215. 

The potential severity of anaphylaxis during anesthesia underscores the interest of developing a rational approach to reduce its incidence by identifying potential risk factors before surgery. Recommendations concerning the identification of population at risk of peroperative anaphylaxis, who would benefit from preoperative investigation, have been proposed [10]. 

From the above, derives the fundamental concept that the newborn infant must be maintained in an adequate degree of hydration and in electrolyte balance in order for the infant to thrive. In some cases, where for one reason or other, the infant is not able to take fluids by mouth in the normal manner, one may need to resort to supplementary fluid therapy by vein. For a rational approach to this problem one needs to have available from the clinical chemical laboratory> rapid response in order to continuously monitor changes in electrolyte levels so that fluids can be modified so as to correct these abnormal-ities. 

Neurotransmitter receptors have evolved as one of the key components in the ability of the central nervous system to coordinate the behaviour of the whole animal, to process and respond to sensory input, and to adapt to change in the environment. These same receptors are therefore ideal targets for drug action because of their central role in the activity of the nervous system. A rational approach to the development of new therapeutic strategies involving the action of drugs at receptors in the nervous system is based on knowledge of receptor structure, distribution and function. 

In the face of the failure of rational approaches in the treatment of AzD it is perhaps not surprising that there have been many less rational ones. These include the use of vasodilators and nootropics. The former, such as hydergine, a mixture of ergot alkaloids, are intended to increase cerebral blood flow and neuronal metabolism despite some reduction in blood pressure, while the latter, like piracetam, are metabolic stimulants that increase cerebral metabolism and ATP production. Neither are of proven value in AzD. 

Leahy, D. E., Morris, J. J., Taylor, P. J., Wait, A. R. Membranes and their models towards a rational choice of partitioning system. In QSAR Rational Approaches to the Design of Bioactive Compounds, Silipo, G., Vittoria, A. (eds.), Elsevier, Amsterdam, 1991, pp. 75-82. 

Scherrer, R. A. The treatment of ionizable compounds in quantitative structure-activity smdies with special consideration to ion partitioning. In Pesticide Synthesis Throi h Rational Approaches (ACS Symp. Ser. 255), Magee, P. S., Kohn, G. K., Menn, J. J. (eds.), American Chemical Society, Washington, DC, 1984, pp. 225-246. 

---